Clinical Trials Browser

Phase 1 × Neoplasms × sintilimab × Clear all

NCT02937116 2022-10-14

First in Human Study of IBI308 in Chinese Subjects With Advanced Solid Tumors

Phase 1 Completed

233 enrolled 30 charts

Neoplasms

NCT04400851 2020-09-03

Sintilimab in the Treatment of Advanced and Refractory Pediatric Malignant Tumors

Phase 1 Unknown

Neoplasms